Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore S Lawrence

Showing results (21-30 of 389) with videos related to

Pageof 39
Sort By:
Cancer Journal (Sudbury, Mass.)|May 8, 2004
The role of radiotherapy in the treatment of liver metastasesLaura A Dawson, Theodore S Lawrence
Cancer Biology & Therapy|January 19, 2006
Hitting the target: measuring EGFR response to tyrosine kinase inhibitorsMukesh K Nyati, Theodore S Lawrence
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S Lawrence
Cancer Journal (Sudbury, Mass.)|April 9, 2008
From the guest editors. Hepatocellular carcinomaMelanie B Thomas, Theodore S Lawrence
Seminars in Radiation Oncology|August 14, 2002
Small-molecule tyrosine kinase inhibitors as radiosensitizersTheodore S Lawrence, Mukesh K Nyati
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2015
Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response PathwaysMeredith A Morgan, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Antimetabolite radiosensitizersDonna S Shewach, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastasesEdgar Ben-Josef, Theodore S Lawrence
American Journal of Translational Research|December 8, 2009
Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa BYao Dai, Theodore S Lawrence, Liang Xu
Seminars in Radiation Oncology|October 3, 2006
The clinical application of intensity-modulated radiation therapyRandall K Ten Haken, Theodore S Lawrence
Pageof 39

Showing results (21-30 of 389) with videos related to

Sort By:
Pageof 39
Cancer Journal (Sudbury, Mass.)|May 8, 2004
The role of radiotherapy in the treatment of liver metastasesLaura A Dawson, Theodore S Lawrence
Cancer Biology & Therapy|January 19, 2006
Hitting the target: measuring EGFR response to tyrosine kinase inhibitorsMukesh K Nyati, Theodore S Lawrence
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2018
No Sugar Added: A New Strategy to Inhibit Glioblastoma Receptor Tyrosine KinasesDaniel R Wahl, Theodore S Lawrence
Cancer Journal (Sudbury, Mass.)|April 9, 2008
From the guest editors. Hepatocellular carcinomaMelanie B Thomas, Theodore S Lawrence
Seminars in Radiation Oncology|August 14, 2002
Small-molecule tyrosine kinase inhibitors as radiosensitizersTheodore S Lawrence, Mukesh K Nyati
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2015
Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response PathwaysMeredith A Morgan, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Antimetabolite radiosensitizersDonna S Shewach, Theodore S Lawrence
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Using a bigger hammer: the role of stereotactic body radiotherapy in the management of oligometastasesEdgar Ben-Josef, Theodore S Lawrence
American Journal of Translational Research|December 8, 2009
Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa BYao Dai, Theodore S Lawrence, Liang Xu
Seminars in Radiation Oncology|October 3, 2006
The clinical application of intensity-modulated radiation therapyRandall K Ten Haken, Theodore S Lawrence
Pageof 39